Company Profiles

driven by the PitchBook Platform

Antabio

Description

Provider of discovery and development services of molecule compounds to treat severe infections. The company develops new drugs that block the virulence of bacteria and make antibiotics more effective.

2009

Founded

PRIVATE

Status

11-50

Employees

Accelerator/Inc

Latest Deal Type

$387k

Total Amount Raised

1

Investors

Description

Provider of discovery and development services of molecule compounds to treat severe infections. The company develops new drugs that block the virulence of bacteria and make antibiotics more effective.

Website:

www.antabio.com

Ownership Status

Privately held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

436 Rue Pierre et Marie Curie 31670 LabegeFrance
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Antabio's full profile, request a free trial.

Antabio Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Antabio Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Individual InvestorAngel (individual)Minority000 0000000 0000
Individual Investor Angel (individual)

Antabio Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Marc Lemonnier Ph.DCo-Founder & Chief Executive Officer
Aymeric Dugray Ph.DCo-Founder, Chief Operating Officer & Chief Financial Officer
Marc Lemonnier Ph.D Co-Founder & Chief Executive Officer
Aymeric Dugray Ph.D Co-Founder, Chief Operating Officer & Chief Financial Officer
Request full access to PitchBook